...
vani-img

Vivani Medical Inc., Common Stock

VANI

NAQ

$1.32

+$0.01

(0.76%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$77.60M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
121.61K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
3.52
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$0.84 L
$4.8 H
$1.32

About Vivani Medical Inc., Common Stock

Vivani Medical, Inc., a preclinical stage biopharmaceutical company, engages in the development of miniaturized and subdermal implants that treat chronic diseases. The company uses its NanoPortal implant technology to develop and potentially commercialize drug implant candidates in the treatment of chronic disease, medication non-adherence. Its pipeline includes NPM-115, a high-dose exenatide implant candidate is in preclinical stage development for the treatment of chronic weight management in patients with obesity or overweight; NPM-119, an exenatide implant candidate is in preclinical stage development for the treatment of patients with type 2 diabetes; NPM-139, a miniature, subdermal GLP-1 implant in development for chronic weight management; and OKV-119, an exenatide implant is under development for metabolic diseases in cats including for the treatment of obesity and diabetes. The company is headquartered in Alameda, California. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameVANISectorS&P500
1-Week Return-0.75%-3.72%-0.05%
1-Month Return--1.85%2.75%
3-Month Return4.76%-11.4%7.4%
6-Month Return-7.69%-4.41%10.47%
1-Year Return53.49%4.13%27.57%
3-Year Return-76.34%0.3%29.56%
5-Year Return-92.78%36.62%89.3%
10-Year Return-99.6%106.81%206.09%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue3.38M1.00K260.00--[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":0.03,"profit":true},{"date":"2021-12-31","value":0.01,"profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Cost of Revenue2.15M167.00K345.00K381.00K357.00K[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":7.76,"profit":true},{"date":"2021-12-31","value":16.03,"profit":true},{"date":"2022-12-31","value":17.7,"profit":true},{"date":"2023-12-31","value":16.59,"profit":true}]
Gross Profit1.23M(167.00K)(345.00K)(381.00K)(357.00K)[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":-13.61,"profit":false},{"date":"2021-12-31","value":-28.12,"profit":false},{"date":"2022-12-31","value":-31.05,"profit":false},{"date":"2023-12-31","value":-29.1,"profit":false}]
Gross Margin36.31%(16700.00%)(132692.31%)--[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":-45989.65,"profit":false},{"date":"2021-12-31","value":-365417.53,"profit":false},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Operating Expenses31.82M9.24M13.32M21.24M26.96M[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":29.04,"profit":true},{"date":"2021-12-31","value":41.86,"profit":true},{"date":"2022-12-31","value":66.75,"profit":true},{"date":"2023-12-31","value":84.73,"profit":true}]
Operating Income(30.60M)(9.24M)(13.32M)(21.24M)(26.96M)[{"date":"2019-12-31","value":-3059700000,"profit":false},{"date":"2020-12-31","value":-924300000,"profit":false},{"date":"2021-12-31","value":-1332300000,"profit":false},{"date":"2022-12-31","value":-2124100000,"profit":false},{"date":"2023-12-31","value":-2696500000,"profit":false}]
Total Non-Operating Income/Expense-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Pre-Tax Income(33.59M)(9.28M)(12.77M)(13.89M)(25.65M)[{"date":"2019-12-31","value":-3359200000,"profit":false},{"date":"2020-12-31","value":-927900000,"profit":false},{"date":"2021-12-31","value":-1277300000,"profit":false},{"date":"2022-12-31","value":-1388900000,"profit":false},{"date":"2023-12-31","value":-2565200000,"profit":false}]
Income Taxes362.00K147.70K(641.00K)(7.35M)-[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":40.8,"profit":true},{"date":"2021-12-31","value":-177.07,"profit":false},{"date":"2022-12-31","value":-2030.94,"profit":false},{"date":"2023-12-31","value":"-","profit":true}]
Income After Taxes-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Income From Continuous Operations-(9.28M)(12.77M)(13.89M)(26.91M)[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-927900000,"profit":false},{"date":"2021-12-31","value":-1277300000,"profit":false},{"date":"2022-12-31","value":-1388900000,"profit":false},{"date":"2023-12-31","value":-2691000000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(33.59M)(9.28M)(12.13M)(6.54M)(25.65M)[{"date":"2019-12-31","value":-3359200000,"profit":false},{"date":"2020-12-31","value":-927900000,"profit":false},{"date":"2021-12-31","value":-1213200000,"profit":false},{"date":"2022-12-31","value":-653700000,"profit":false},{"date":"2023-12-31","value":-2565200000,"profit":false}]
EPS (Diluted)(6.54)(2.43)(0.24)(0.28)(0.50)[{"date":"2019-12-31","value":-654,"profit":false},{"date":"2020-12-31","value":-243,"profit":false},{"date":"2021-12-31","value":-24,"profit":false},{"date":"2022-12-31","value":-28.3,"profit":false},{"date":"2023-12-31","value":-50,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

VANI
Cash Ratio 3.13
Current Ratio 3.41

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

VANI
ROA (LTM) -29.29%
ROE (LTM) -86.10%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

VANI
Debt Ratio Lower is generally better. Negative is bad. 0.57
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.43

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

VANI
Trailing PE NM
Forward PE NM
P/S (TTM) 0.00
P/B 4.23
Price/FCF NM
EV/R 0.00
EV/Ebitda NM

FAQs

What is Vivani Medical Inc. share price today?

Vivani Medical Inc. (VANI) share price today is $1.32

Can Indians buy Vivani Medical Inc. shares?

Yes, Indians can buy shares of Vivani Medical Inc. (VANI) on Vested. To buy Vivani Medical Inc. from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in VANI stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Vivani Medical Inc. be purchased?

Yes, you can purchase fractional shares of Vivani Medical Inc. (VANI) via the Vested app. You can start investing in Vivani Medical Inc. (VANI) with a minimum investment of $1.

How to invest in Vivani Medical Inc. shares from India?

You can invest in shares of Vivani Medical Inc. (VANI) via Vested in three simple steps:

  • Click on Sign Up or Invest in VANI stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Vivani Medical Inc. shares
What is Vivani Medical Inc. 52-week high and low stock price?

The 52-week high price of Vivani Medical Inc. (VANI) is $4.8. The 52-week low price of Vivani Medical Inc. (VANI) is $0.84.

What is Vivani Medical Inc. price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Vivani Medical Inc. (VANI) is

What is Vivani Medical Inc. price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Vivani Medical Inc. (VANI) is 4.23

What is Vivani Medical Inc. dividend yield?

The dividend yield of Vivani Medical Inc. (VANI) is 0.00%

What is the Market Cap of Vivani Medical Inc.?

The market capitalization of Vivani Medical Inc. (VANI) is $77.60M

What is Vivani Medical Inc.’s stock symbol?

The stock symbol (or ticker) of Vivani Medical Inc. is VANI

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top